The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and antitumor activity of chimeric antigen receptor modified T cells in patients with chemotherapy refractory metastatic pancreatic cancer.
 
Gregory Lawrence Beatty
Stock and Other Ownership Interests - Advaxis; Johnson & Johnson
Honoraria - Janssen
Consulting or Advisory Role - GlaxoSmithKline; Incyte
Research Funding - Novartis
Other Relationship - Advaxis
 
Mark H. O'Hara
No Relationships to Disclose
 
Anne M Nelson
No Relationships to Disclose
 
Maureen McGarvey
No Relationships to Disclose
 
Drew A. Torigian
No Relationships to Disclose
 
Simon F. Lacey
Research Funding - Novartis
 
Jan J. Melenhorst
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Bruce Levine
Research Funding - Adaptimmune; Novartis; Sangamo Bioscience
Patents, Royalties, Other Intellectual Property - Novartis
Travel, Accommodations, Expenses - The Medicines Company
 
Gabriela Plesa
No Relationships to Disclose
 
Carl H. June
Stock and Other Ownership Interests - Celldex; GlobeImmune; Immune Design
Honoraria - MedImmune; Novartis; Pfizer
Consulting or Advisory Role - Celldex; GlobeImmune; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; Office of Naval Research; IP and patent royalties